Bruker Corporation BRKR
Set alert
55.69 USD -1.38 -2.42%
At close · Nov 2
55.73 +0.04 +0.07%
After hours · Nov 2, 4:00 PM ET
55.15 Day range 57.20
32.37 52-week range 66.98
- YTD
- +18.21%
- 1 year
- +43.01%
- Open
- 57.07
- Prev close
- 57.07
- Mkt cap
- 8.48B
- Vol
- 1.89M
- Avg vol
- 2.29M
- EPS
- -0.70
- P/E
- 0.00
- Div yield
- 0.32%
More statistics
- Low
- 55.15
- High
- 57.20
- Forward P/E
- 23.17
- Beta
- 1.27
- Short ratio
- 5.27
- Inst. own
- 95.54%
- Dividend
- 0.20
- Ex-div date
- Sep 20, 2026
- Earnings
- Nov 4, 2026
- 50-d avg
- 58.90
- 200-d avg
- 50.22
- 1y target
- 63.83
Analyst view
Consensus: buy
Buy
Price target (mean) 63.83 +14.6% upside
Now 55.69
- Target (low)
- 50.00
- Target (mean)
- 63.83
- Target (high)
- 80.00
Ratings (0m) 13 6 buy · 6 hold · 1 sell
- Strong buy1
- Buy5
- Hold6
- Sell1
- Strong sell0
Recommendation trend
- This month 13
- 1 month ago 13
- 2 months ago 13
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.41601 | 0.39 – 0.44849 | 0.45 | -7.6% | 865.19M | +0.5% | 12 |
| Next quarter | 0.90212 | 0.87 – 0.91289 | 0.59 | +52.9% | 1.03B | +5.1% | 12 |
| Current year | 2.12 | 2.10 – 2.14 | 1.83 | +15.8% | 3.56B | +3.5% | 13 |
| Next year | 2.40 | 2.28 – 2.47 | 2.12 | +13.4% | 3.70B | +4.2% | 13 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 14, 2026 | JP Morgan | Downgrade | Overweight | Neutral |
| Oct 13, 2026 | TD Cowen | Maintained | Hold | Hold |
| Oct 7, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 1, 2026 | Guggenheim | Maintained | Buy | Buy |
| Sep 29, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Sep 9, 2026 | UBS | Maintained | Neutral | Neutral |
| Aug 5, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Jul 8, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Jul 7, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Jun 29, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jun 24, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jun 8, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| May 7, 2026 | UBS | Maintained | Neutral | Neutral |
| May 7, 2026 | Citigroup | Maintained | Neutral | Neutral |
| May 7, 2026 | TD Cowen | Maintained | Hold | Hold |
| May 7, 2026 | Barclays | Maintained | Overweight | Overweight |
| Apr 15, 2026 | Barclays | Maintained | Overweight | Overweight |
| Apr 14, 2026 | Barclays | Maintained | Overweight | Overweight |
| Mar 30, 2026 | Guggenheim | Maintained | Buy | Buy |
| Feb 13, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Feb 13, 2026 | Goldman Sachs | Maintained | Sell | Sell |
| Feb 13, 2026 | TD Cowen | Maintained | Hold | Hold |
| Feb 13, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jan 26, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jan 16, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Jan 7, 2026 | TD Cowen | Maintained | Hold | Hold |
| Jan 5, 2026 | Guggenheim | Maintained | Buy | Buy |
| Dec 15, 2025 | Barclays | Maintained | Overweight | Overweight |
| Dec 15, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Dec 15, 2025 | Wells Fargo | Maintained | Overweight | Overweight |